The patch’s unprecedented stretchability and signal fidelity enable reliable, long‑term sEMG monitoring, accelerating wearable health tech and advanced prosthetic control.
The demand for wearable electromyography (sEMG) solutions has outpaced existing technologies, which often sacrifice conductivity or mechanical compliance. Conventional Ag/AgCl gels provide reliable signals but quickly degrade under motion, limiting their use in dynamic applications such as sports analytics or prosthetic control. MEAP‑S addresses this gap by integrating gold microelectrodes on a stretchable SEBS substrate, achieving a rare blend of high electrical performance and elasticity that maintains intimate skin contact even during vigorous movement.
Technical innovation lies in the multilayer architecture: photolithography defines precise gold patterns while the ultrathin SEBS dielectric ensures uniform strain distribution and isolates channels to prevent crosstalk. The resulting electrode array reaches a conductivity of over 10^5 S m⁻¹ and tolerates 100 % tensile strain without signal degradation. With a channel density of 100 cm⁻², the system captures high‑resolution muscle activation maps, delivering signal‑to‑noise ratios above 27 dB during prolonged wear. These metrics surpass many rigid or loosely coupled alternatives, offering clinicians and engineers a robust data source for complex gesture decoding.
The broader impact of MEAP‑S extends to neuromuscular assessment, continuous health monitoring, and next‑generation human‑machine interaction. Its biocompatibility and comfort enable long‑term studies, while the scalable fabrication process promises cost‑effective mass production. As industries push toward seamless brain‑computer and muscle‑computer interfaces, such high‑fidelity, stretchable sEMG platforms will become foundational components, driving innovation in rehabilitation robotics, virtual reality control, and personalized fitness tracking.
Comments
Want to join the conversation?
Loading comments...